Together against pain: a London - Rome collaboration

Up to 80% of patients develop chronic pain (CIPN) with chemotherapy and this can lead to interruption of anti-cancer treatment and may significantly reduce the quality of life of cancer survivors.

This new collaboration study the mechanisms underlying CIPN and provide data for researchers and clinicians to develop effective treatment of the condition.

Area

Biology

UCL leads

• Maria Maiaru, Cell & Developmental Biology

Partner leads

Università di Roma

• Francesco Cecconi